University of Toronto homepage

Eitan Amir

Professor

Temerty Faculty of Medicine, Department of Medicine

Orcid identifier0000-0002-3706-525X
  • Professor
    Temerty Faculty of Medicine, Department of Medicine
  • 416 946 4501 Ext.5181 (Work)
  • 416 946 6546 (Fax)
  • Princess Margaret Cancer Centre, Division of Medical Oncology and Hematology, 610 University Ave, Toronto, ON, M5G 2M9, Canada

GRANTS

  • Showing page 1 out of 1
Showing page 1, grants 1 to 23 of 23
  • SPONSORED RESEARCH AGREEMENT
    The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
    Canadian Institutes of Health Research1 Sep 2025 - 31 Aug 2029
  • SPONSORED RESEARCH AGREEMENT
    The JUdicious Surveillance for Trastuzumab Induced Cardiotox icity in the First Year (JUSTIFY) Randomized Controlled Tria l
    CIHR - Grants (CIHR)1 Mar 2025 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    The JUdicious Surveillance for Trastuzumab Induced Cardiotox icity in the First Year (JUSTIFY) Randomized Controlled Tria l
    CIHR - Grants (CIHR)1 Oct 2024 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    At-home Breast Oncology care Delivered with E-Health solutions – The ABODE Study for Patients Undergoing Neoadjuvant Chemotherapy
    AHSC AFP Innovation Fund1 Apr 2024 - 31 Mar 2026
  • SPONSORED RESEARCH AGREEMENT
    Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in pa tients with advanced cancer
    CIHR - Grants (CIHR)1 Apr 2024 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    A Multi-Centre Non-Inferiority Randomized Controlled Trial o f STOPping Cardiac MEDications in Patients with Normalized C ancer Therapy Related Cardiac Dysfunction - The STOP-MED CTR CD Trial
    CIHR - Awards (CIHR)1 Sep 2023 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    A Multi-Centre Non-Inferiority Randomized Controlled Trial o f STOPping Cardiac MEDications in Patients with Normalized C ancer Therapy Related Cardiac Dysfunction – The STOP-MED CTR CD Trial
    UHN MSH ACADEMIC MEDICAL ORG1 Apr 2023 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    A phase II trial assessing the additional palliative benefit of physiological high-does vitamin D for breast cancer pati ents with bone metastases using pain scores and biochemical markers of bone turnover.
    Vitamin D Society1 Apr 2023 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    Dantrolene as an adjunct to chemotherapy with doxorubicin to reduce or eliminate associated cardiotoxicity to extend or eliminate lifetime maximum dosing
    Princess Margaret Cancer Center Innovation Accelerator Fund (IAF)1 Apr 2023 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    Novel Dantrolene Indication: Dantrolene to reduce the cardio toxicity of Doxorubicin
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2023 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    TD Fund for emergency medicine and indigenous health partner ship
    UHN Foundations1 Apr 2023 - 31 Mar 2025
  • SPONSORED RESEARCH AGREEMENT
    Precision cardiovascular disease profiling and risk prediction in cancer survivors (PROGRESS): A prospective cohort study.
    Heart and Stroke Foundation of Canada1 Jul 2022 - 30 Jun 2024
  • SPONSORED RESEARCH AGREEMENT
    The Impact of COVID-19 on the Diagnosis and Treatment of Breast Cancer (TICTOC): a population-based study. Canadian Institutes of Health Research
    Canadian Institutes of Health Research1 Apr 2022 - 31 Mar 2024
  • SPONSORED RESEARCH AGREEMENT
    A phase II trial assessing the additional palliative benefit of physiological high-does vitamin D for breast cancer pati ents with bone metastases using pain scores and biochemical markers of bone turnover.
    Vitamin D Society1 Apr 2017 - 31 Dec 2022
  • SPONSORED RESEARCH AGREEMENT
    Breast Medical Oncology Fellowship Fund - Purpose: To Suppor t The Activities Of Medical Oncology Breast Cancer Fellows A t Princess Margaret Cancer Centre/Oci. Funding Various Donor s. Fund Set-Up Requested By: Shannon Stuart
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2016 - 31 Mar 2017
  • SPONSORED RESEARCH AGREEMENT
    Hold 'Em For Life Breast Cancer Research Fund - Purpose: To Support The Genomic Sequencing Project Related To Breast Can cer At Princess Margaret Cancer Centre/Oci.
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2016 - 31 Mar 2017
  • SPONSORED RESEARCH AGREEMENT
    Neoadjuvant Breast Cancer Treatment Program Fund - Purpose: To Facilitate The Creation And Operationalizing Of The Neoad juvant Breast Cancer Treatment Program
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2016 - 31 Mar 2017
  • SPONSORED RESEARCH AGREEMENT
    Hold 'Em For Life Breast Cancer Research Fund. Researchto Su pport The Genomic Sequencing Project Related To Breast Cance r At Princess Margaret Cancer Centre/Oci.
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2015 - 31 Mar 2016
  • SPONSORED RESEARCH AGREEMENT
    Impact That Pcodr Has On Cancer Drug Funding In Canada
    Inactive - St Michael's Hospital He (St. Michael's Hospital)1 Apr 2015 - 31 Mar 2016
  • SPONSORED RESEARCH AGREEMENT
    PMHF: A Randomised Pilot study comparing the efficacy of 4-w eekly versus 12-weekly intravenous Bisphosphonnate therapy i n women with low risk bone metastases from breast cancer usi ng bone resorption markers.
    University Health Network1 Apr 2013 - 31 Mar 2014
  • SPONSORED RESEARCH AGREEMENT
    purpose: to provide funding for research for residents and f ellows funds: donations from individuals and honourariums (s ic) notes: fund start up requested by eitan amir
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2013 - 31 Mar 2014
  • SPONSORED RESEARCH AGREEMENT
    purpose: to support the genomic sequencing project related t o breast cancerat pmh/oci.
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2013 - 31 Mar 2014
  • SPONSORED RESEARCH AGREEMENT
    Fund : Hold 'em for Life Breast Cancer Research Fund ; Resea rch purpose: to support the genomic sequencing project relat ed to breast cancerat pmh/oci.
    Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2012 - 31 Mar 2013